{"id":70249,"date":"2026-04-13T15:57:36","date_gmt":"2026-04-13T10:27:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=70249"},"modified":"2026-04-13T15:57:37","modified_gmt":"2026-04-13T10:27:37","slug":"why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/","title":{"rendered":"Why Is Zydus Lifesciences Share Price Falling? Key Reasons &amp; Share Price Target 2026"},"content":{"rendered":"<p>Zydus Lifesciences share price is down -33% from its 52-week high of Rs 1,300, trading at Rs 860 as of April 2026. At its 52-week low of Rs 820, the stock has already given up significant gains \u2014 and investors are asking the same question: is this a buying opportunity or a value trap?<\/p><p>The Zydus Lifesciences share price falling is not random market noise. There are specific, identifiable reasons driving the decline \u2014 and this article examines each of them with real data, sector context, and the analyst consensus on what Zydus Lifesciences is worth.<\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2014 Get Free Investment Predictions on Univest<\/strong><\/a>.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Why_Is_Zydus_Lifesciences_Share_Price_Falling_Key_Reasons\" title=\"Why Is Zydus Lifesciences Share Price Falling? Key Reasons\">Why Is Zydus Lifesciences Share Price Falling? Key Reasons<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_1_Asacol_HD_Exclusivity_Expiry_%E2%80%94_Revenue_Impact\" title=\"Reason 1: Asacol HD Exclusivity Expiry \u2014 Revenue Impact\">Reason 1: Asacol HD Exclusivity Expiry \u2014 Revenue Impact<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_2_US_Generics_Pricing_Pressure\" title=\"Reason 2: US Generics Pricing Pressure\">Reason 2: US Generics Pricing Pressure<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_3_Biologics_and_Biosimilar_Pipeline_Delays\" title=\"Reason 3: Biologics and Biosimilar Pipeline Delays\">Reason 3: Biologics and Biosimilar Pipeline Delays<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_4_Saroglitazar_%E2%80%94_Delayed_FDA_Approval\" title=\"Reason 4: Saroglitazar \u2014 Delayed FDA Approval\">Reason 4: Saroglitazar \u2014 Delayed FDA Approval<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Reason_5_US_Tariff_Risk_on_Indian_Pharma_Exports\" title=\"Reason 5: US Tariff Risk on Indian Pharma Exports\">Reason 5: US Tariff Risk on Indian Pharma Exports<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Zydus_Lifesciences_Financial_Snapshot\" title=\"Zydus Lifesciences Financial Snapshot\">Zydus Lifesciences Financial Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Can_Zydus_Lifesciences_Recover_Future_Outlook\" title=\"Can Zydus Lifesciences Recover? Future Outlook\">Can Zydus Lifesciences Recover? Future Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Zydus_Lifesciences_Share_Price_Target_2026\" title=\"Zydus Lifesciences Share Price Target 2026\">Zydus Lifesciences Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Short-Term_Target_3-6_Months\" title=\"Short-Term Target (3-6 Months)\">Short-Term Target (3-6 Months)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#12-Month_Analyst_Consensus_Target\" title=\"12-Month Analyst Consensus Target\">12-Month Analyst Consensus Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Long-Term_Target_FY28\" title=\"Long-Term Target (FY28)\">Long-Term Target (FY28)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q1_Why_is_Zydus_Lifesciences_share_price_falling_in_2026\" title=\"Q1. Why is Zydus Lifesciences share price falling in 2026?\">Q1. Why is Zydus Lifesciences share price falling in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q2_What_is_Zydus_Lifesciences_share_price_target_2026\" title=\"Q2. What is Zydus Lifesciences share price target 2026?\">Q2. What is Zydus Lifesciences share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q3_Should_I_buy_Zydus_Lifesciences_at_current_levels\" title=\"Q3. Should I buy Zydus Lifesciences at current levels?\">Q3. Should I buy Zydus Lifesciences at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q4_What_is_Zydus_Lifesciencess_market_cap_and_PE_ratio\" title=\"Q4. What is Zydus Lifesciences&#8217;s market cap and P\/E ratio?\">Q4. What is Zydus Lifesciences&#8217;s market cap and P\/E ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Q5_What_can_trigger_recovery_in_Zydus_Lifesciences_share_price\" title=\"Q5. What can trigger recovery in Zydus Lifesciences share price?\">Q5. What can trigger recovery in Zydus Lifesciences share price?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-is-zydus-lifesciences-share-price-falling-key-reasons-amp-share-price-target-2026\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_Is_Zydus_Lifesciences_Share_Price_Falling_Key_Reasons\"><\/span><strong>Why Is Zydus Lifesciences Share Price Falling? Key Reasons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research Pieces on Univest<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_1_Asacol_HD_Exclusivity_Expiry_%E2%80%94_Revenue_Impact\"><\/span><strong>Reason 1: Asacol HD Exclusivity Expiry \u2014 Revenue Impact<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Zydus Lifesciences&#8217; Asacol HD (mesalamine extended-release for ulcerative colitis) had US FDA exclusivity that provided significantly above-average margins. The expiry of this exclusivity and entry of generic competitors has removed a Rs 400-500 crore annualised high-margin revenue stream from FY26.<\/p><p>US generics exclusivities are finite. Zydus has historically been excellent at finding new exclusivities \u2014 but the pipeline timing means there&#8217;s always a gap between one exclusivity ending and the next beginning, creating earnings volatility.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_2_US_Generics_Pricing_Pressure\"><\/span><strong>Reason 2: US Generics Pricing Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The US generic drug market continues to face structural pricing pressure as pharmacy benefit managers (PBMs) and large pharmacy chains consolidate and negotiate harder with generic manufacturers. Price erosion of 4-6% per year is the structural reality for most generic APIs and formulations.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_3_Biologics_and_Biosimilar_Pipeline_Delays\"><\/span><strong>Reason 3: Biologics and Biosimilar Pipeline Delays<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Zydus has been building a biosimilar and biologics pipeline for the regulated US market. Several programmes, including insulin aspart (biosimilar insulin) and other injectable biologics, have faced FDA approval delays. These delays push out the expected revenue contribution from the higher-margin biosimilar business.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_4_Saroglitazar_%E2%80%94_Delayed_FDA_Approval\"><\/span><strong>Reason 4: Saroglitazar \u2014 Delayed FDA Approval<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Saroglitazar (for Non-Alcoholic Steatohepatitis \/ NASH) is Zydus&#8217;s most important innovative molecule in Phase 2\/3 trials. Any delay in FDA approval timeline removes a key re-rating catalyst.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reason_5_US_Tariff_Risk_on_Indian_Pharma_Exports\"><\/span><strong>Reason 5: US Tariff Risk on Indian Pharma Exports<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>While the 26% US reciprocal tariff has an exception for pharmaceutical APIs, there is ongoing policy uncertainty. Any expansion of tariffs to finished pharma products would directly impact Zydus&#8217;s US revenue.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zydus_Lifesciences_Financial_Snapshot\"><\/span><strong>Zydus Lifesciences Financial Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Parameter<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td>CMP<\/td><td>Rs 860<\/td><\/tr><tr><td>52-Week High<\/td><td>Rs 1,300<\/td><\/tr><tr><td>52-Week Low<\/td><td>Rs 820<\/td><\/tr><tr><td>Decline from Peak<\/td><td>-33%<\/td><\/tr><tr><td>Market Cap<\/td><td>Rs 86,000 Cr<\/td><\/tr><tr><td>P\/E Ratio<\/td><td>26x<\/td><\/tr><tr><td>P\/B Ratio<\/td><td>4.8x<\/td><\/tr><tr><td>Promoter Holding<\/td><td>74.9%<\/td><\/tr><tr><td>FII Holding<\/td><td>10.4%<\/td><\/tr><tr><td>DII Holding<\/td><td>12.6%<\/td><\/tr><tr><td>Sector<\/td><td>Pharmaceuticals \/ Specialty Generics<\/td><\/tr><\/tbody><\/table><\/figure><p>Track <strong>Zydus Lifesciences<\/strong> live fundamentals and peer comparisons on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p><p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> for daily research updates.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Can_Zydus_Lifesciences_Recover_Future_Outlook\"><\/span><strong>Can Zydus Lifesciences Recover? Future Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Zydus Lifesciences at Rs 860 and 26x P\/E is one of the better-valued large-cap pharma stocks. The biosimilar pipeline (insulin aspart, adalimumab, etc.) represents significant optionality that is not fully priced in. Recovery to Rs 1,050-1,200 requires at least one key biosimilar approval in the US and stable base business performance. The founding Patel family&#8217;s 74.9% promoter holding provides governance confidence.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zydus_Lifesciences_Share_Price_Target_2026\"><\/span><strong>Zydus Lifesciences Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Subscribe to Univest Pro for SEBI-registered analyst recommendations<\/strong><\/a>.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Short-Term_Target_3-6_Months\"><\/span><strong>Short-Term Target (3-6 Months)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Short-term Zydus Lifesciences share price target is Rs 820-960, based on current technical setup and near-term fundamental catalyst timeline. The 52-week low of Rs 820 is the key support level \u2014 a sustained break below this would be a significant bearish signal.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"12-Month_Analyst_Consensus_Target\"><\/span><strong>12-Month Analyst Consensus Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus 12-month Zydus Lifesciences share price target is Rs 1,050-1,200, implying meaningful upside from the current Rs 860. This assumes the key headwinds identified in this article begin to resolve.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Long-Term_Target_FY28\"><\/span><strong>Long-Term Target (FY28)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>In a full recovery scenario, the Zydus Lifesciences share price target for FY28 is Rs 1,400-1,600. This bull case requires the fundamental concerns in this article to show clear reversal over the next 4-6 quarters.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q1_Why_is_Zydus_Lifesciences_share_price_falling_in_2026\"><\/span><strong>Q1. Why is Zydus Lifesciences share price falling in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Zydus Lifesciences share price is falling primarily due to the reasons detailed in this article. The stock has declined -33% from its 52-week high of Rs 1,300 to the current Rs 860. Key factors include sector headwinds, earnings pressure, and broader market conditions. Review all factors before making any investment decision.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q2_What_is_Zydus_Lifesciences_share_price_target_2026\"><\/span><strong>Q2. What is Zydus Lifesciences share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Analyst consensus 12-month Zydus Lifesciences share price target is Rs 1,050-1,200. Short-term target is Rs 820-960 and long-term FY28 target in a recovery scenario is Rs 1,400-1,600. These are analyst estimates and not guaranteed returns.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q3_Should_I_buy_Zydus_Lifesciences_at_current_levels\"><\/span><strong>Q3. Should I buy Zydus Lifesciences at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>This article does not provide personalised investment advice. Zydus Lifesciences is trading at Rs 860 with a 52-week range of Rs 820 to Rs 1,300. The risk-reward depends on your investment horizon and risk tolerance. Consult a SEBI-registered financial advisor before investing.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q4_What_is_Zydus_Lifesciencess_market_cap_and_PE_ratio\"><\/span><strong>Q4. What is Zydus Lifesciences&#8217;s market cap and P\/E ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Zydus Lifesciences&#8217;s market capitalisation is Rs 86,000 Cr with a trailing P\/E of 26x and price-to-book ratio of 4.8x. Promoter holding is 74.9%, FII 10.4%, DII 12.6%.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Q5_What_can_trigger_recovery_in_Zydus_Lifesciences_share_price\"><\/span><strong>Q5. What can trigger recovery in Zydus Lifesciences share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Recovery triggers for Zydus Lifesciences include: resolution of the specific headwinds identified in this article, positive quarterly results showing reversal of stressed metrics, and broad market recovery. Monitor quarterly results and management commentary closely.<\/p><p><strong>Disclaimer: <\/strong>For educational purposes only. Not investment advice. Consult a SEBI-registered financial advisor. Investments are subject to market risk.<\/p><p>For more analysis, visit <a href=\"https:\/\/univest.in\/blogs\">Univest Blogs<\/a>.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span>Recent Articles<span class=\"ez-toc-section-end\"><\/span><\/h2><p>&nbsp;<a href=\"https:\/\/univest.in\/blogs\/why-is-krbl-share-price-falling\"><strong>Why is KRBL Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-reliance-infrastructures-share-price-falling\"><strong>Why is Reliance Infrastructures Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-mahanagar-gas-share-price-falling\"><strong>Why is Mahanagar Gas Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/why-is-happiest-minds-share-price-falling\"><strong>Why is Happiest Minds Share Price Falling? Check Next Share Price Target&nbsp;<\/strong><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Zydus Lifesciences share price is down -33% from its 52-week high of Rs 1,300, trading at Rs 860 as of April 2026. At its 52-week low of Rs 820, the stock has already given up significant gains \u2014 and investors are asking the same question: is this a buying opportunity or a value trap? The<\/p>\n","protected":false},"author":27,"featured_media":70250,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3818],"class_list":["post-70249","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-falling"],"metadata":{"_edit_lock":["1776076333:27"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["842"],"rank_math_seo_score":["79"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_focus_keyword":["Zydus Lifesciences Share Price"],"_thumbnail_id":["70250"],"_edit_last":["27"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["7931"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/04\/13155310\/zydus-lifesciences-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=70249"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70249\/revisions"}],"predecessor-version":[{"id":70264,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/70249\/revisions\/70264"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/70250"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=70249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=70249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=70249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}